Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2774390 | Endocrinología y Nutrición | 2007 | 5 Pages |
Abstract
Application of the Framingham score to determine 10-year risk for CHD in the population studied revealed that most subjects had a low risk (> 80%). No significant differences were found between men and women with and without MS in different risk categories. However, certain studies have demonstrated that Framingham scoring and the ATP-III-NCEP underestimate risk in women, mainly in those with a history of premature CHD or MS. Therefore, other tools should be used to predict cardiovascular risk with greater reliability.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Marino Tagle-Luzárraga, Fausto Gómez-Vargas, Lynn Guerrero-RodrÃguez, Andrea Tagle-Morla, MarÃa Fernanda Franco-Bajaña,